Please Wait
Applying Filters...
menu
    • menu
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Veranova: A CDMO that manages complexity with confidence.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Teverelix

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Medicus Pharma To Unveil Long-Acting Teverelix Data At AACE 2026
    Medicus Pharma To Unveil Long-Acting Teverelix Data At AACE 2026

    15 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/15/3274336/0/en/Medicus-Pharma-to-Present-New-Teverelix-Data-at-AACE-2026-Demonstrating-Long-Acting-Hormone-Suppression.html

    GLOBENEWSWIRE
    15 Apr 2026
    Share Share
    Medicus Pharma Reveals 2025 Financials And Corporate Update
    Medicus Pharma Reveals 2025 Financials And Corporate Update

    25 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-25/medicus-pharma-reports-full-year-2025-financial-results-and-provides-corporate-update

    PHARMIWEB
    25 Mar 2026
    Share Share
    Medicus Gets FDA OK to Start Teverelix Ph 2b Prostate Study
    Medicus Gets FDA OK to Start Teverelix Ph 2b Prostate Study

    10 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/10/3235197/0/en/Medicus-Pharma-Receives-FDA-Study-May-Proceed-Clearance-For-Teverelix-Phase-2b-Study-in-Advanced-Prostate-Cancer-Patients-with-High-Cardiovascular-Risk.html

    GLOBENEWSWIRE
    10 Feb 2026
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.